China Money Network
Login
Join

Chinese Biotech Firm Denovo Biopharma Nets $42M In Series B Round

  • October 31, 2019 — 15:17 CST

This Data Is Locked!

This area is available only to Subscribers.

Denovo Biopharma, a Chinese biotechnology company providing a novel biomarker solution to personalize drug development, has raised RMB300 million (US$42.6 million) in a series B... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: